Blood hormone levels can predict long-term breast cancer risk
Blood hormone tests can predict a woman's risk for developing postmenopausal breast cancer for up to 20 years, according to a study led by Xuehong Zhang, MD, Channing Division of Network Medicine, Brigham and Women's Hospital ...
Cancer
Oct 18, 2012 |
not rated yet |
0
Noninvasive measurement enables use of IFP as potential biomarker for tumor aggressiveness
Researchers validated a method of noninvasive imaging that provides valuable information about interstitial fluid pressure of solid tumors and may aid in the identification of aggressive tumors, according to the results of ...
Cancer
Oct 01, 2012 |
not rated yet |
0
Lack of oxygen in cancer cells leads to growth and metastasis
(Medical Xpress)—It seems as if a tumor deprived of oxygen would shrink. However, numerous studies have shown that tumor hypoxia, in which portions of the tumor have significantly low oxygen concentrations, ...
Cancer
Sep 13, 2012 |
5 / 5 (5) |
1
|
Fasting makes brain tumors more vulnerable to radiation therapy
A new study from USC researchers is the first to show that controlled fasting improves the effectiveness of radiation therapy in cancer treatments, extending life expectancy in mice with aggressive brain tumors.
Cancer
Sep 11, 2012 |
not rated yet |
0
|
Team finds biological indicator of aggressive, recurrent forms of prostate cancer
(Medical Xpress)—In a study to decipher clues about how prostate cancer cells grow and become more aggressive, Johns Hopkins urologists have found that reduction of a specific protein is correlated with the aggressiveness ...
Cancer
Aug 27, 2012 |
5 / 5 (1) |
0
|
Lack of sleep found to be a new risk factor for aggressive breast cancers
Lack of sleep is linked to more aggressive breast cancers, according to new findings published in the August issue of Breast Cancer Research and Treatment by physician-scientists from University Hospitals Case Medical Center's ...
Cancer
Aug 27, 2012 |
5 / 5 (1) |
0
|
Blood test could guide treatment for kidney cancer
A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to doctors at Duke Cancer Institute.
Cancer
Aug 13, 2012 |
not rated yet |
0
Tumor cells' inner workings predict cancer progression
Using a new assay method to study tumor cells, researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center have found evidence of clonal evolution in chronic ...
Cancer
Jul 27, 2012 |
5 / 5 (1) |
0
|
Neural precursor cells induce cell death in certain brain tumors
Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors. Now researchers of the Max ...
Cancer
Jul 23, 2012 |
not rated yet |
0
|
Promising developments in early diagnosis and treatment of mesothelioma
New results presented at 3rd European Lung Cancer Conference in Geneva, Switzerland show important steps being made to improve the diagnosis and treatment of malignant pleural mesothelioma, an aggressive cancer of the outer ...
Cancer
Apr 18, 2012 |
5 / 5 (1) |
0
Mechanism found connecting metastatic breast cancer and arthritis
Working with mouse models, researchers have found a strong connection between autoimmune arthritis and increased aggressiveness in metastatic breast cancer. The connection appears to involve the tendency of autoimmune arthritis ...
Immunology
Apr 01, 2012 |
not rated yet |
0
|
Study reveals trigger that may speed melanoma growth
(HealthDay) -- Growth of the deadly skin cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen.
Cancer
Mar 28, 2012 |
5 / 5 (3) |
0
|
Longer treatment with cancer drug following removal of GI tumor results in improved survival
Among patients with a high risk of recurrence of a gastrointestinal stromal tumor following surgery for its removal, patients who received imatinib (a drug to treat certain cancers) for 3 years instead of 1 had improved recurrence-free ...
Cancer
Mar 27, 2012 |
not rated yet |
0
Breaking the backbone of triple-negative breast cancers
Putting the brakes on an abundant growth-promoting protein causes breast tumors to regress, according to a study published on March 19th in the Journal of Experimental Medicine.
Cancer
Mar 19, 2012 |
not rated yet |
0
Inhibiting cell migration in breast cancer
(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research together with colleagues from the University of Fribourg have discovered a signaling mechanism controlling mobility ...
Cancer
Mar 14, 2012 |
5 / 5 (1) |
0
|
